Together with the detection of the majority of BRAF genomic variants at cDNA level, this highlights the particular importance of alterations in this pathway in terms of both occurrence and phenotypical impact in the context of the heterogeneous mutational pattern of MM. This evidence concerns the gene BRAF and Miyoshi myopathy.